Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
2000 3
2001 2
2002 1
2004 2
2006 2
2007 1
2008 2
2009 2
2010 1
2011 2
2012 3
2013 3
2014 4
2015 5
2016 2
2017 1
2018 3
2019 3
2020 3
2021 2
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

43 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Influenza Vaccination Strategies: Comparing Inactivated and Live Attenuated Influenza Vaccines.
Sridhar S, Brokstad KA, Cox RJ. Sridhar S, et al. Vaccines (Basel). 2015 Apr 24;3(2):373-89. doi: 10.3390/vaccines3020373. Vaccines (Basel). 2015. PMID: 26343192 Free PMC article. Review.
There are two main types of vaccines available: the parenteral inactivated influenza vaccine and the intranasal live attenuated influenza vaccine. ...Inactivated vaccines are standardized according to the prese …
There are two main types of vaccines available: the parenteral inactivated influenza vaccine and the intranasal …
Influenza virus: immunity and vaccination strategies. Comparison of the immune response to inactivated and live, attenuated influenza vaccines.
Cox RJ, Brokstad KA, Ogra P. Cox RJ, et al. Scand J Immunol. 2004 Jan;59(1):1-15. doi: 10.1111/j.0300-9475.2004.01382.x. Scand J Immunol. 2004. PMID: 14723616 Free article. Review.
The virus is continuously undergoing antigenic change and thus bypasses the host's acquired immunity to influenza. Despite the improvement in antiviral therapy during the last decade, vaccination is still the most effective method of prophylaxis. ...Specifica …
The virus is continuously undergoing antigenic change and thus bypasses the host's acquired immunity to influenza. Despite the …
Inactivated and live-attenuated seasonal influenza vaccines boost broadly neutralizing antibodies in children.
Yegorov S, Celeste DB, Gomes KB, Ang JC, Vandenhof C, Wang J, Rybkina K, Tsui V, Stacey HD, Loeb M, Miller MS. Yegorov S, et al. Cell Rep Med. 2022 Feb 3;3(2):100509. doi: 10.1016/j.xcrm.2022.100509. eCollection 2022 Feb 15. Cell Rep Med. 2022. PMID: 35243417 Free PMC article.
However, little is known about if or how bNAbs are induced by vaccination in more immunologically naive children. Here, we describe the impact of repeated seasonal influenza vaccination and vaccine type on induction of bNAbs against group 1 influenz
However, little is known about if or how bNAbs are induced by vaccination in more immunologically naive children. Here, we describe t …
A Live-Attenuated Prime, Inactivated Boost Vaccination Strategy with Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccines Provides Protection in Ferrets: A Confirmatory Study.
Nachbagauer R, Krammer F, Albrecht RA. Nachbagauer R, et al. Vaccines (Basel). 2018 Jul 25;6(3):47. doi: 10.3390/vaccines6030047. Vaccines (Basel). 2018. PMID: 30044403 Free PMC article.
This group was compared to a second group that received a cH8/1N1 inactivated vaccine followed by a cH5/1N1 inactivated vaccine. ...The results support the further development of chimeric hemagglutinin-based vaccination strategies. …
This group was compared to a second group that received a cH8/1N1 inactivated vaccine followed by a cH5/1N1 inactiva
Comparison of Adjuvanted-Whole Inactivated Virus and Live-Attenuated Virus Vaccines against Challenge with Contemporary, Antigenically Distinct H3N2 Influenza A Viruses.
Abente EJ, Rajao DS, Santos J, Kaplan BS, Nicholson TL, Brockmeier SL, Gauger PC, Perez DR, Vincent AL. Abente EJ, et al. J Virol. 2018 Oct 29;92(22):e01323-18. doi: 10.1128/JVI.01323-18. Print 2018 Nov 15. J Virol. 2018. PMID: 30185589 Free PMC article.
Using antigenically representative H3N2 viruses, we compared whole inactivated virus (WIV) and live-attenuated influenza virus (LAIV) vaccines for protection against challenge with antigenically distinct H3N2 viruses in pigs. ...Currently …
Using antigenically representative H3N2 viruses, we compared whole inactivated virus (WIV) and live-attenuated
Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
de Boer PT, Nagy L, Dolk FCK, Wilschut JC, Pitman R, Postma MJ. de Boer PT, et al. Value Health. 2021 Jan;24(1):19-31. doi: 10.1016/j.jval.2020.10.011. Epub 2020 Dec 11. Value Health. 2021. PMID: 33431149 Free article.
Costs and QALYs were discounted at 4% and 1.5% annually. RESULTS: At an assumed coverage of 50%, adding pediatric vaccination for 2- to 17-year-olds with quadrivalent live-attenuated vaccine to the current vaccination program for elderly and med …
Costs and QALYs were discounted at 4% and 1.5% annually. RESULTS: At an assumed coverage of 50%, adding pediatric vaccination for 2- …
Comparative Study of the Temperature Sensitive, Cold Adapted and Attenuated Mutations Present in the Master Donor Viruses of the Two Commercial Human Live Attenuated Influenza Vaccines.
Rodriguez L, Blanco-Lobo P, Reilly EC, Maehigashi T, Nogales A, Smith A, Topham DJ, Dewhurst S, Kim B, Martínez-Sobrido L. Rodriguez L, et al. Viruses. 2019 Oct 10;11(10):928. doi: 10.3390/v11100928. Viruses. 2019. PMID: 31658679 Free PMC article.
Vaccination represents the most effective strategy to prevent such infections and/or to reduce viral disease. Two major types of influenza vaccines are approved for human use: inactivated influenza vaccines (IIVs) and liv
Vaccination represents the most effective strategy to prevent such infections and/or to reduce viral disease. Two major types
Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany.
Damm O, Eichner M, Rose MA, Knuf M, Wutzler P, Liese JG, Krüger H, Greiner W. Damm O, et al. Eur J Health Econ. 2015 Jun;16(5):471-88. doi: 10.1007/s10198-014-0586-4. Epub 2014 May 25. Eur J Health Econ. 2015. PMID: 24859492 Free PMC article.
In 2011, intranasally administered live attenuated influenza vaccine (LAIV) was approved in the EU for prophylaxis of seasonal influenza in 2-17-year-old children. ...The discounted incremental cost-effectiveness ratio was <euro> 1,228 per …
In 2011, intranasally administered live attenuated influenza vaccine (LAIV) was approved in the EU for prophylax …
Randomized evaluation of live attenuated vs. inactivated influenza vaccines in schools (RELATIVES) pilot study: a cluster randomized trial.
Kwong JC, Pereira JA, Quach S, Pellizzari R, Dusome E, Russell ML, Hamid JS, Feinberg Y, Winter AL, Gubbay JB, Sirtonski B, Moher D, Sider D, Finkelstein M, Loeb M; Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Program Delivery and Evaluation Group. Kwong JC, et al. Vaccine. 2015 Jan 15;33(4):535-41. doi: 10.1016/j.vaccine.2014.11.044. Epub 2014 Dec 6. Vaccine. 2015. PMID: 25488331 Free article. Clinical Trial.
OBJECTIVES: To better understand the feasibility of offering intranasal live attenuated influenza vaccines (LAIV) through schools, we assessed uptake, stakeholder acceptability, and cost of school-based delivery of LAIV compared to IIV. ...Howev …
OBJECTIVES: To better understand the feasibility of offering intranasal live attenuated influenza vaccines (LAIV …
Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
Wan Z, Cardenas Garcia S, Liu J, Santos J, Carnaccini S, Geiger G, Ferreri L, Rajao D, Perez DR. Wan Z, et al. J Virol. 2018 Oct 12;92(21):e01025-18. doi: 10.1128/JVI.01025-18. Print 2018 Nov 1. J Virol. 2018. PMID: 30135124 Free PMC article.
Live attenuated influenza virus vaccines (LAIVs) may provide superior responses compared to inactivated vaccines because the former can better elicit a combination of humoral and cellular responses by mimicking a natural infection.
Live attenuated influenza virus vaccines (LAIVs) may provide superior responses compared to inactivate
43 results